RxDoctor Payments Data

Chad Stephens, DO

Interventional Pain Medicine · Southlake, TXNPI 1659372290

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (45.6%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Spinal Simplicity, LLC at 40.9% of the total. Reporting peaked in 2021 at $183,062 and has fallen 53.2% since, to $85,687 in 2025. Among interventional pain medicine clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,039,517in general payments, 2019–2025

Across 1,043 payments — averaging $996.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Spinal Simplicity, LLC$425K
  • Avanos Medical$424K
  • Stimwave Technologies Incorporated$65K
  • Boston Scientific$41K
  • Vertiflex, Inc.$38K
  • Ferring Pharmaceuticals Inc.$25K
  • plus $22K from 14 others
$59,874in ownership & investment interests, 2019–2025

Across 4 payments — averaging $14,968 each. An ownership or investment interest held by the physician or an immediate family member.

  • Spinal Simplicity, LLC$60K

What the payments were for

  • Consulting fees$473,86646%
  • Speaking & faculty fees$216,12621%
  • Travel & lodging$183,87018%
  • Food & beverage$27,1093%
  • Education$136,71113%
  • Gifts$2490%
  • Entertainment$1,5850%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,039,517 in reported general payments places this provider in the 95th percentile of 287 interventional pain medicine providers in Texas.

See all interventional pain medicine providers in Texas

Medicare billing

Part B allowed, 2024
$128,102
Medicare patients
162
Services billed
1,080

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl13$13,360
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen375$13,081
Fentanyl16$3,674
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen72$3,524
Oxycodone Hcl25$1,271
Cyclobenzaprine Hcl103$680
Gabapentin49$658
Tramadol Hcl46$576
Tizanidine Hcl22$308
Celecoxib21$186
Pregabalin20$145
Acetaminophen-CodeineAcetaminophen With Codeine12$137
Methocarbamol11$96
Methadone Hcl11$94

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Southlake

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →